First of all light volume...second of all, they already knew the previous test missed targets, so why the sellofff? Todays news was half decent. $1.50 in cash et al.!!
Sentiment: Strong Buy
Cash doesn't make a company. No product approval in the near future means cash burn and then what do you have? A broke company and no cash. I'd like to know what Arqule's clinical trials are going forward.
go to website and see for yourself